Release 5 R6 Ballot (1st Draft)

This page is part of the FHIR Specification (v5.0.0: R5 - STU v6.0.0-ballot1: Release 6 Ballot (1st Draft) (see Ballot Notes ). This is the The current published version in it's permanent home (it will always be available at this URL). is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Example MedicationRequest/medrx0306 (Narrative)

Pharmacy Work Group Maturity Level : N/A Standards Status : Informative Compartments : Encounter , Patient , Practitioner

This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile MedicationRequest .

Generated Narrative: MedicationRequest

Resource MedicationRequest "medrx0306"

identifier : id: 12345689 (use: OFFICIAL)

status : active

intent : order

Medications

- Reference
*

code : Myleran 2mg tablet, film coated ( National drug codes #76388-713-25) #76388-713-25 "MYLERAN, 25 TABLET, FILM COATED in 1 BOTTLE (76388-713-25) (package)")

subject : Patient/pat1: Donald Duck "Donald DUCK"

authoredOn : 2015-01-15

requester : Practitioner/f007: Patrick Pump "Simone HEPS"

Reasons

- Concept
* Chronic myeloid Leukemia (disorder) ( SNOMED CT #92818009)

dosageInstruction

sequence : 1

text : 6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count. With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL

timing : Once per 1 days

route : Oral route (qualifier value) ( SNOMED CT #26643006)

doseAndRate

 

Other examples that reference this example:

  • MedicationAdministration/Oral Chemo
  • MedicationDispense/Oral Chemo

    •  

    Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.